Formulary guidance and transparency from P&T to point of care

Trends That Matter for Cancer Spending

Posted by Matt Breese on Apr 6, 2017

Find me on:

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is cancer spending and outcomes.

The Journal of the American Medical Association (JAMA) revealed that cancer treatment expenses, including medical services and drugs, account for approximately 7% of disease-based health expenditures in the US.

In addition, "Cancer medications were among the top three for specialty drug spending in 2015, behind medications for inflammatory conditions and multiple sclerosis," according to the Kaiser Family Foundation (KFF).

In the graphic below, KFF and JAMA outline trends for specialty drug spending:

Cancer Spending.png

Subscribe to the MMIT blog for more insights on trends affecting pharmaceutical manufacturers, providers and payers.

Subscribe for Weekly Trends that Matter

Topics: Specialty, Industry Trends